(58 days)
No
The document describes a tool for editing segmentations produced by other algorithms, not a device that uses AI/ML itself for segmentation or analysis.
No.
The device is a software tool for editing image segmentation masks, which are used to refine the input for other analytical algorithms; it does not directly treat or diagnose a disease or condition.
No
The device is a tool for editing and correcting segmentation masks, not for making a diagnosis. Its purpose is to optimize segmentations for further analysis, which would then be used for diagnosis.
Yes
The device is described as "Imbio Segmentation Editing Tool (SET) Software" and its function is to modify or create segmentation masks from anatomical images. The description focuses entirely on the software's capabilities and its interaction with other software components (Imbio algorithms, Core Computing Platform, PACS workstation). There is no mention of any accompanying hardware component that is part of the device itself.
Based on the provided information, the Imbio Segmentation Editing Tool Software is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, tissue) to provide information about a person's health.
- Device function: The Imbio Segmentation Editing Tool Software processes medical images (anatomical images) and segmentation masks. It does not analyze biological specimens.
- Intended Use: The intended use is to modify or create segmentation contours on medical images, which is an image processing task, not an in vitro diagnostic test.
- Input: The input is anatomical images and segmentation results, not biological samples.
The device is clearly described as a software tool for image post-processing and segmentation editing, which falls under the category of medical image analysis software, not IVD.
N/A
Intended Use / Indications for Use
The Imbio Segmentation Editing Tool Software is used by trained medical professionals asa tool to modify the contours of segmentation masks produced by Imbio algorithms or to manually create segmentation mask contours. The Segmentation Editing Tool can provide further support to the users of Imbio's algorithms.
Product codes
LLZ
Device Description
Imbio Segmentation Editing Tool (SET) Software is a segmentation editing tool designed to allow users to optimize segmentations calculated by Imbio's fully-automated suite of algorithms (Each algorithm is a separate Imbio program and either has or will be submitted for regulatory approval independently). Imbio is building a suite of medical image post-processing applications that run automatically after data transfer off the medical imaging scanner. Automatic image segmentation is often an essential step in Imbio's analyses. To date, the automatic segmentation algorithms used in Imbio's applications have been robust, however segmentation failures do occur. The purpose of the Segmentation Editing Tool is to provide customers with a tool to locally correct poor segmentations. Additionally, if the Imbio automatic segmentation fails such that it is unable to produce a result, this tool can be used to semi-manually draw the segmentation required for analysis.
SET reads in anatomical images used in an automatic segmentation algorithm and the results of the automated segmentation algorithm (if available). The user is then able to locally correct insufficiencies in the segmentation result, or create a segmentation mask from scratch. The finalized segmentation mask is then pushed back to Imbio's Core Computing Platform and the job is re-processed.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained medical professionals including, but not limited to, radiologists, oncologists and medical imaging technologists. It is intended to locally correct errors in the segmentation masks produced by Imbio's automatic segmentation algorithms Additionally, if the Imbio segmentation algorithm is unable to produce a segmentation mask, this tool could be used to semi-manually create a segmentation mask. The application will be accessed most typically from a PACS workstation over a modern Internet browser (e.g. IE>10).
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Non-clinical testing was done to show validity of SET software. Results can be seen in Software Test Protocol/Report attached in Appendix E/Appendix F.
Design validation was performed using the Imbio Segmentation Editing Tool Software in actual and simulated use settings.
This technology is not new; therefore, a clinical study was not considered necessary prior to release. Additionally, there was no clinical testing required to support the medical device as the indications for use is equivalent to the predicate device. Usability testing was completed for this product to ensure proper use of the product by intended users.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
March 16, 2018
Imbio, LLC % Vipul Goel Sr. Manager 807 Broadwav Street NE. #350 MINNEAPOLIS MN 55413
Re: K180129
Trade/Device Name: Imbio Segmentation Editing Tool Software Regulation Number: 21 CFR 892,2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: January 11, 2018 Received: January 17, 2018
Dear Vipul Goel:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
1
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone
(1-800-638-2041 or 301-796-7100).
Sincerely,
Michael D'Hara For
Robert Ochs. Ph.D Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K180129
Device Name
Imbio Segmentation Editing Tool Software
Indications for Use (Describe)
The Imbio Segmentation Editing Tool Software is used by trained medical professionals asa tool to modify the contours of segmentation masks produced by Imbio algorithms or to manually create segmentation mask contours. The Segmentation Editing Tool can provide further support to the users of Imbio's algorithms.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ☑ Prescription Use (Part 21 CFR 801 Subpart D) | |
| ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the word "imbio" in a sans-serif font. The letters are a light blue color. The background is white. The letters are slightly blurred.
5.0 510(k) Summary
| Table 3: 510(k) summary |
|---|
| Table 3: 510(k) summary (As required by Section 21 CFR 807.92(c)) | |
|---|---|
| Submitter: | Imbio LLC |
| 807 Broadway ST NE, #350 | |
| Minneapolis MN 55413 USA | |
| Contact Person: | Vipul Goel |
| Sr. Manager, QA/RA | |
| Telephone: 612-520-7360 | |
| Email: vipulgoel@imbio.com | |
| Date Prepared: | Jan 11, 2018 |
| Trade Name: | Imbio Segmentation Editing Tool Software |
| Common/Usual Name: | Software Accessory for Radiological Image Processing Device |
| Classification: | System, Image Processing, Radiological |
| 21 CFR 892.2050 | |
| Product Code LLZ, Class II | |
| Product Code: | LLZ, Class II |
| Manufacturer: | Imbio LLC |
| 807 Broadway ST NE, #350 | |
| Minneapolis MN 55413 USA | |
| Establishment | |
| Registration: | MD6099829 |
| Predicate Device: | Manufacturer: MIM 5.2 (Brachy) |
| Trade name: MIM Software Inc | |
| 510(k) Number: K103576 | |
| Date Cleared: 18-Feb-2011 | |
| 510(k) Summary | (As required by Section 21 CFR 807.92(c)) |
| Device Description | Imbio Segmentation Editing Tool (SET) Software is a |
| segmentation editing tool designed to allow users to optimize | |
| segmentations calculated by Imbio's fully-automated suite of | |
| algorithms (Each algorithm is a separate Imbio program and | |
| either has or will be submitted for regulatory approval | |
| independently). Imbio is building a suite of medical image | |
| post-processing applications that run automatically after data | |
| transfer off the medical imaging scanner. Automatic image | |
| segmentation is often an essential step in Imbio's analyses. To | |
| date, the automatic segmentation algorithms used in Imbio's | |
| applications have been robust, however segmentation | |
| failures do occur. The purpose of the Segmentation Editing | |
| Tool is to provide customers with a tool to locally correct poor | |
| segmentations. Additionally, if the Imbio automatic | |
| segmentation fails such that it is unable to produce a result, | |
| this tool can be used to semi-manually draw the | |
| segmentation required for analysis. | |
| SET reads in anatomical images used in an automatic | |
| segmentation algorithm and the results of the automated | |
| segmentation algorithm (if available). The user is then able to | |
| locally correct insufficiencies in the segmentation result, or | |
| create a segmentation mask from scratch. The finalized | |
| segmentation mask is then pushed back to Imbio's Core | |
| Computing Platform and the job is re-processed. | |
| Intended Use | Segmentation Editing Tool Software is intended for use by |
| trained medical professionals including, but not limited to, | |
| radiologists, oncologists and medical imaging technologists. It | |
| is intended to locally correct errors in the segmentation | |
| masks produced by Imbio's automatic segmentation | |
| algorithms Additionally, if the Imbio segmentation algorithm | |
| is unable to produce a segmentation mask, this tool could be | |
| used to semi-manually create a segmentation mask. The | |
| application will be accessed most typically from a PACS | |
| workstation over a modern Internet browser (e.g. IE>10). | |
| 510(k) Summary | (As required by Section 21 CFR 807.92(c)) |
| Summary of Technical | |
| Comparisons | The fundamental functional characteristics of SET are very |
| similar to the analogous functions included in MIM 5.2 | |
| (Brachy). The primary differences between the proposed and | |
| predicate devices are that: | |
| Imbio SET is not a standalone application and can only | |
| be used in conjunction with other Imbio algorithms | |
| installed on Imbio's platform. Imbio SET has contour snapping and interpolation | |
| features that serve as workflow optimization tools for | |
| contouring tasks involving large regions of interest. Imbio SET has a much more limited set of features | |
| than MIM 5.2 (Brachy). | |
| Non-Clinical Testing | Non-clinical testing was done to show validity of SET |
| software. Results can be seen in Software Test | |
| Protocol/Report attached in Appendix E/Appendix F | |
| Design Validation | Design validation was performed using the Imbio |
| Segmentation Editing Tool Software in actual and simulated | |
| use settings. | |
| Clinical Testing | This technology is not new; therefore, a clinical study was not |
| considered necessary prior to release. Additionally, there was | |
| no clinical testing required to support the medical device as | |
| the indications for use is equivalent to the predicate device. | |
| Usability testing was completed for this product to ensure | |
| proper use of the product by intended users. | |
| Conclusion: | The Imbio Segmentation Editing Tool Software has the same |
| technological characteristics as the predicate device in that it | |
| has a similar intended use, same general operating principle. | |
| The specific details of the predicate device may vary from | |
| those of Imbio Segmentation Editing Tool Software. | |
| It has been shown in this 510(k) submission that the | |
| differences between the Imbio Segmentation Editing Tool | |
| Software and the MIM 5.2 (Brachy) (K103576) do not raise | |
| any questions regarding safety and effectiveness. The Imbio | |
| Segmentation Editing Tool Software, as designed and | |
| manufactured, is substantially equivalent to, and as safe and |
4
0 n
5